Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleClinical Investigation

Molecular Imaging Biomarkers in Cardiooncology: A View on Established Technologies and Future Perspectives

David Kersting, Ilektra-Antonia Mavroeidi, Stephan Settelmeier, Robert Seifert, Martin Schuler, Ken Herrmann, Tienush Rassaf and Christoph Rischpler
Journal of Nuclear Medicine November 2023, 64 (Supplement 2) 29S-38S; DOI: https://doi.org/10.2967/jnumed.122.264868
David Kersting
1Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, University of Duisburg–Essen, Essen, Germany;
2German Cancer Consortium, Partner Site University Hospital Essen, Essen, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ilektra-Antonia Mavroeidi
2German Cancer Consortium, Partner Site University Hospital Essen, Essen, Germany;
3Department of Medical Oncology, West German Cancer Center, University Hospital Essen, University of Duisburg–Essen, Essen, Germany; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephan Settelmeier
4Department of Cardiology and Vascular Medicine, West German Heart and Vascular Center Essen, University Hospital Essen, University of Duisburg–Essen, Essen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert Seifert
1Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, University of Duisburg–Essen, Essen, Germany;
2German Cancer Consortium, Partner Site University Hospital Essen, Essen, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martin Schuler
2German Cancer Consortium, Partner Site University Hospital Essen, Essen, Germany;
3Department of Medical Oncology, West German Cancer Center, University Hospital Essen, University of Duisburg–Essen, Essen, Germany; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ken Herrmann
1Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, University of Duisburg–Essen, Essen, Germany;
2German Cancer Consortium, Partner Site University Hospital Essen, Essen, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tienush Rassaf
4Department of Cardiology and Vascular Medicine, West German Heart and Vascular Center Essen, University Hospital Essen, University of Duisburg–Essen, Essen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christoph Rischpler
1Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, University of Duisburg–Essen, Essen, Germany;
2German Cancer Consortium, Partner Site University Hospital Essen, Essen, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 64 no. Supplement 2 29S-38S
DOI 
https://doi.org/10.2967/jnumed.122.264868
PubMed 
37918843

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication February 16, 2023
  • Revision received September 5, 2023
  • Published online November 2, 2023.

Copyright & Usage 
© 2023 by the Society of Nuclear Medicine and Molecular Imaging.

Author Information

  1. David Kersting1,2,
  2. Ilektra-Antonia Mavroeidi2,3,
  3. Stephan Settelmeier4,
  4. Robert Seifert1,2,
  5. Martin Schuler2,3,
  6. Ken Herrmann1,2,
  7. Tienush Rassaf4 and
  8. Christoph Rischpler1,2
  1. 1Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, University of Duisburg–Essen, Essen, Germany;
  2. 2German Cancer Consortium, Partner Site University Hospital Essen, Essen, Germany;
  3. 3Department of Medical Oncology, West German Cancer Center, University Hospital Essen, University of Duisburg–Essen, Essen, Germany; and
  4. 4Department of Cardiology and Vascular Medicine, West German Heart and Vascular Center Essen, University Hospital Essen, University of Duisburg–Essen, Essen, Germany
  1. For correspondence or reprints, contact David Kersting (david.kersting{at}uni-due.de).
View Full Text

Statistics from Altmetric.com

Cited By...

  • 8 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Exercise, cancer, and the cardiovascular system: clinical effects and mechanistic insights
    Simon Wernhart, Tienush Rassaf
    Basic Research in Cardiology 2024 120 1
  • Cardiac PET/MRI: Recent Developments and Future Aspects
    Remigiusz Kazimierczyk, Karol A. Kaminski, Stephan G. Nekolla
    Seminars in Nuclear Medicine 2024 54 5
  • FAPI PET Imaging Supports Clinical Decision Making in Academic Cardiology Practice
    Stephan Settelmeier, Lukas Kessler, Zohreh Varasteh, Amir A. Mahabadi, Lars Michel, Maria Papathanasiou, Christina Laschinsky, Christoph Rischpler, Wolfgang P. Fendler, Thomas Schlosser, Lale Umutlu, Ken Herrmann, Tienush Rassaf, David Kersting
    JACC: Cardiovascular Imaging 2024 17 7
  • The Evolution of Cardiac Nuclear Imaging
    Frank M. Bengel, Marcelo F. Di Carli
    Journal of Nuclear Medicine 2023 64 Supplement 2
  • Artificial Intelligence in Nuclear Cardiac Imaging: Novel Advances, Emerging Techniques, and Recent Clinical Trials
    Ilana S. Golub, Abhinav Thummala, Tyler Morad, Jasmeet Dhaliwal, Francisco Elisarraras, Ronald P. Karlsberg, Geoffrey W. Cho
    Journal of Clinical Medicine 2025 14 6
  • 18F-Fluorodeoxyglucose Imaging for Assessing Cardiovascular Inflammation
    Nagara Tamaki, Tadao Aikawa, Osamu Manabe
    Diagnostics 2025 15 5
  • Cardiac Complications of Radiation Therapy: A Narrative Review of Recent Literature
    Elisheva Eisenberg, William H. Frishman, Wilbert S. Aronow
    Cardiology in Review 2025
  • Ultrasonic Detection of Myocardial Changes in Tumor Patients after Chemotherapy: Current Situation and Prospect
    肖 林
    Advances in Clinical Medicine 2025 15 03

Article usage

Article usage: November 2023 to April 2025

AbstractFullPdf
Nov 2023665592361
Dec 2023255174143
Jan 202430811579
Feb 202412910551
Mar 20241147760
Apr 2024120120770
May 2024857551
Jun 20243610146
Jul 20242714856
Aug 20243915256
Sep 2024258653
Oct 2024446662
Nov 2024257039
Dec 2024167935
Jan 2025255338
Feb 20252427057
Mar 20251910735
Apr 202557444
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 64 (Supplement 2)
Journal of Nuclear Medicine
Vol. 64, Issue Supplement 2
November 1, 2023
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Molecular Imaging Biomarkers in Cardiooncology: A View on Established Technologies and Future Perspectives
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Molecular Imaging Biomarkers in Cardiooncology: A View on Established Technologies and Future Perspectives
David Kersting, Ilektra-Antonia Mavroeidi, Stephan Settelmeier, Robert Seifert, Martin Schuler, Ken Herrmann, Tienush Rassaf, Christoph Rischpler
Journal of Nuclear Medicine Nov 2023, 64 (Supplement 2) 29S-38S; DOI: 10.2967/jnumed.122.264868

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Molecular Imaging Biomarkers in Cardiooncology: A View on Established Technologies and Future Perspectives
David Kersting, Ilektra-Antonia Mavroeidi, Stephan Settelmeier, Robert Seifert, Martin Schuler, Ken Herrmann, Tienush Rassaf, Christoph Rischpler
Journal of Nuclear Medicine Nov 2023, 64 (Supplement 2) 29S-38S; DOI: 10.2967/jnumed.122.264868
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • CARDIOTOXICITY OF CANCER THERAPIES
    • NOVEL BIOMARKERS IN NUCLEAR CARDIOONCOLOGY
    • CLINICAL IMPLICATIONS AND FUTURE PERSPECTIVES
    • CONCLUSION
    • DISCLOSURE
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • First-in-Human Study of 18F-Labeled PET Tracer for Glutamate AMPA Receptor [18F]K-40: A Derivative of [11C]K-2
  • Detection of HER2-Low Lesions Using HER2-Targeted PET Imaging in Patients with Metastatic Breast Cancer: A Paired HER2 PET and Tumor Biopsy Analysis
  • [11C]Carfentanil PET Whole-Body Imaging of μ-Opioid Receptors: A First in-Human Study
Show more Clinical Investigation

Similar Articles

Keywords

  • Molecular imaging
  • cardiotoxicity
  • Nuclear cardiology
  • cardiooncology
SNMMI

© 2025 SNMMI

Powered by HighWire